• The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $1.50

    Source: Buzz FX / 19 Feb 2025 15:26:12   America/Chicago


    The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $1.50 Written by MarketBeat February 19, 2025 Share Link copied to clipboard. Pacific Biosciences of California ( NASDAQ:PACB - Get Free Report )
    Read more...
Share on,